MYC and neoplasm: In tumor microenvironments with high lactate levels, FOXP3 can further reprogram Treg cells by inhibiting c-Myc and glycolysis, and enhancing oxidative phosphorylation (OXPHOS), allowing Tregs to better adapt to the high-lactate environment (Ding et al., 2024).